JDS Uniphase Falls off a Cliff

Don't let it get away!

Keep track of the stocks that matter to you.

Help yourself with the Fool's FREE and easy new watchlist service today.

JDS Uniphase (Nasdaq: JDSU  ) shares are plunging today, hurt by a sizeable "earnings miss" yesterday, and guidance that didn't quite meet expectations, either. Investors are right to be upset. The sell-off is justified ... but not for the reasons the mainstream press is citing.

Listen to the professionals, and you'll assume that JDS's $0.13-per-share loss and 11% sales growth justify Thursday's 13% haircut. But that's just one quarter's news -- a brief speedbump on the highway to JDS's prosperity ...

Exit, stage left
... if JDS were on that highway in the first place. It's not. Let's take a break from Wall Street's short-term thinking here for a moment, and look at the bigger picture. Over the course of its fiscal 2008:

  • JDS grew revenue 9.5%
  • It tacked on nearly five percentage points to its gross margin (currently 38.6%).
  • But it posted an operating margin of negative 8.6%, and lost $0.10 per share.

How did JDS turn better gross margins into an even bigger operating loss? By allowing its costs to run amok. R&D spending increased 12% -- but I've got no objection to that. Tech firms need to invest in their tech. But I don't like that JDS increased its selling, general, and administrative spending at twice that rate -- 24%. This surge in operating costs has JDS now posting an operating margin worse than those of Agilent (NYSE: A  ) , Coherent (Nasdaq: COHR  ) , and Finisar (Nasdaq: FNSR  ) -- worse, in fact, than almost anyone other than Jim Cramer fave Bookham (Nasdaq: BKHM  ) .

And by the way, where's the cash?
In addition to its continuing GAAP losses, we have a new reason to chastise JDS today. Remember what I wrote in Tuesday's Foolish Forecast? "Unless we learn tomorrow that free cash flow has fallen off a cliff, this means the buying window remains open to us"?

Well, FCF fell off that cliff. Trending toward $33 million as we headed into Q4, JDS instead generated a bare $9 million for the quarter. (Management has not released the most recent quarter's cash flow statement.) My best estimate now puts free cash flow for the year at $108 million.

Simply put, JDS's projected 15% growth rate does not support its new 21-times-FCF valuation. Until it does, I can't support the stock.

Related Foolishness:

Fool contributor Rich Smith does not own shares of any company named above. The Motley Fool has a disclosure policy.

Read/Post Comments (0) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 712108, ~/Articles/ArticleHandler.aspx, 10/22/2016 1:48:55 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 4 hours ago Sponsored by:
DOW 18,145.71 -16.64 -0.09%
S&P 500 2,141.16 -0.18 -0.01%
NASD 5,257.40 15.57 0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/21/2016 4:00 PM
VIAV $7.19 Down -0.10 -1.37%
Viavi Solutions CAPS Rating: ***
A $45.57 Down -0.48 -1.04%
Agilent Technologi… CAPS Rating: ***
BKHM $0.56 Down +0.00 +0.00%
Bookham CAPS Rating: *
COHR $104.56 Up +1.42 +1.38%
Coherent CAPS Rating: **
FNSR $29.16 Down -0.52 -1.75%
Finisar CAPS Rating: ***